Financials

v3.26.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 8,923,000 $ 6,811,000
Restricted cash 94,000 94,000
Deferred offering costs 570,000 634,000
Prepaid expenses and other current assets 409,000 567,000
TOTAL ASSETS 9,996,000 8,106,000
Current liabilities    
Accounts payable 253,000 748,000
Accrued expenses 2,163,000 1,560,000
Warrant liability 11,000
Total Current Liabilities 2,416,000 2,319,000
Stockholders’ Equity    
Preferred stock value 1,000 1,000
Common stock, par value $0.001, 250,000,000 shares authorized, 35,181,891 and 25,534,173 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively 35,000 26,000
Additional paid in capital 734,381,000 729,661,000
Accumulated deficit (726,837,000) (723,901,000)
Total Stockholders’ Equity 7,580,000 5,787,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 9,996,000 8,106,000
Series L Preferred Stock [Member]    
Stockholders’ Equity    
Preferred stock value

Source

v3.26.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenues
Operating Expenses:    
Research and development 413,000 1,099,000
Selling, general and administrative 2,435,000 833,000
Loss from Operations (2,848,000) (1,932,000)
Other Income (Expense)    
Interest income 67,000 32,000
Interest expense (63,000)
Change in fair value of warrant liability 11,000 126,000
Gain on settlement of vendor payable 998,000
Total Other Income, net 15,000 1,156,000
Net Loss (2,833,000) (776,000)
Dividend on preferred stock (103,000)
Deemed dividend (433,000)
Net Loss attributable to common stockholders’ $ (3,369,000) $ (776,000)
Net Loss Per Share - Basic $ (0.11) $ (0.33)
Net Loss Per Share - Diluted $ (0.11) $ (0.33)
Weighted average common shares outstanding - basic 30,283,031 2,345,087
Weighted average common shares outstanding - diluted 30,283,031 2,345,087

Source

v3.26.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (2,833,000) $ (776,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation 46,000 3,000
Change in fair value of warrant liability (11,000) (126,000)
Changes in operating assets and liabilities:    
(Increase) Decrease in prepaid expenses 222,000 (12,000)
Increase (Decrease) in accounts payable and accrued expenses 108,000 (1,291,000)
Net Cash Used in Operating Activities (2,468,000) (2,202,000)
CASH FLOWS FROM INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES    
Exercise of warrants for cash, net 577,000 616,000
Proceeds from issuance of Series L convertible preferred stock and warrants, net 4,003,000
Net Cash Provided by Financing Activities 4,580,000 616,000
Net Increase (Decrease) in Cash and Cash Equivalents and Restricted Cash 2,112,000 (1,586,000)
Cash and Cash Equivalents and Restricted Cash at Beginning of Period 6,905,000 4,044,000
Cash and Cash Equivalents and Restricted Cash at End of Period 9,017,000 2,458,000
Cash paid during the period for:    
Interest
Income taxes
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES    
Fair value of prefunded warrant and common stock to settle vendor payable $ 847,000

Source